С槼ºÖ±²¥

This phase 2 nonrandomized controlled trial evaluates the safety and response rates of bintrafusp alfa in patients with recurrent or metastatic cervical cancer.

This cohort study estimates the 20-year cumulative risk of breast cancer mortality among women with stage 0 to III unilateral breast cancer according to the type of initial surgery performed.

This nonrandomized controlled trial evaluates the clinical outcomes of atezolizumab treatment before and after chemoradiation therapy for unresectable stage III non–small cell lung cancer (NSCLC).

This single-arm, open-label phase 1 cohort study examines the safety, patient health, and survival outcomes of GC012F in individuals with high-risk newly diagnosed multiple myeloma.

This cohort study examines the incidence of cervical intraepithelial neoplasia during a period of increasing human papillomavirus (HPV) vaccination coverage from 2007 to 2020.

This narrative review describes the identification of male BRCA1/2 pathogenic variant carriers, associated cancer risks, and management recommendations.

This Viewpoint discusses the importance of hormone deprivation–free survival as an end point for both men with prostate cancer and women with breast cancer.

This nonrandomized clinical trial examines 6 escalated exercise therapy dose levels ranging from 90 to 450 minutes per week for men with treatment-naive localized prostate cancer.

This case series examines the association of immune checkpoint inhibitor–based therapies vs best supportive care with the overall survival of patients with unresectable hepatocellular carcinoma and Child-Pugh class B liver dysfunction.

This Viewpoint presents an organizational and social template for medical communities to provide contemporary care for patients with cancer in rural and underserved states.

This cohort study evaluates the association between waterpipe tobacco smoking and the risk of cancer mortality in Vietnam.

This nonrandomized controlled trial aims to determine if a response-adapted radiation therapy strategy will result in excellent disease outcomes while reducing orbital morbidity.

This systematic review and meta-analysis assesses the association between measurable residual disease and progression-free survival in chronic lymphocytic leukemia treated with targeted agents.

This Consensus Statement summarizes new evidence-based recommendations and reaffirms standards for timely initial management of BRAF V600E-variant anaplastic thyroid cancer.

This Viewpoint discusses the end point analyses and results of the RACICALS-RT study.

This cohort study compares survival of high-risk patients with screen-detected pancreatic cancer with a matched cohort from the Surveillance, Epidemiology, and End Results program.

This randomized clinical trial examines adequate early survival rates of treatment with adjuvant gemcitabine plus cisplatin compared with concurrent chemoradiation with capecitabine in patients with resected stage II and stage III gallbladder cancers.

This essay describes the experience of an oncologist in India and palliative care involving grieving families and coconuts.

This study assesses the accuracy of fluorine-18 prostate-specific membrane antigen–1007 positron emission tomography (PET)/computed tomography (CT) compared to multiparametric magnetic resonance imaging (MRI) in locoregional staging of prostate cancer.